MAPT and Alzheimer disease: Interestingly, the levels of kynurenic acid significantly correlated with the AD biomarker phosphorylated tau, supporting the association between sICAM-1 CSF levels and neurodegeneration markers in AD (Wennstrom et al., 2014).